Second Sight Medical Products, Inc. (NASDAQ:EYES – Get Rating) Director Gregg Williams purchased 167,160 shares of the stock in a transaction on Monday, May 23rd. The shares were purchased at an average price of $1.97 per share, with a total value of $329,305.20. Following the acquisition, the director now owns 10,861,456 shares in the company, […]
Second Sight Medical Products, Inc. (NASDAQ:EYES – Get Rating) Director Gregg Williams purchased 387,044 shares of the business’s stock in a transaction that occurred on Wednesday, May 18th. The shares were purchased at an average price of $1.66 per share, for a total transaction of $642,493.04. Following the completion of the acquisition, the director now […]
Second Sight Medical Products (NASDAQ:EYES – Get Rating) and Electromed (NYSE:ELMD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of current […]
Second Sight Medical Products (NASDAQ:EYES – Get Rating) was upgraded by StockNews.com to a “sell” rating in a report issued on Wednesday. NASDAQ EYES traded up $0.03 during trading on Wednesday, hitting $1.51. 140,947 shares of the company’s stock were exchanged, compared to its average volume of 561,321. The stock’s 50 day moving average price […]
Second Sight Medical Products, Inc. (NASDAQ:EYES – Get Rating)’s share price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $1.39 and traded as low as $1.16. Second Sight Medical Products shares last traded at $1.16, with a volume of 184,573 shares traded. […]